Plain-English translation of NCT07691801 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is testing whether a newer, more precise blood test method can help doctors better identify primary aldosteronism—a treatable form of high blood pressure caused by a hormone imbalance. The study compares blood test results from healthy people and patients suspected of having this condition to establish more accurate diagnostic guidelines. Better diagnosis means more people could get the right treatment sooner.
Primary aldosteronism is the most common cause of secondary hypertension (high blood pressure from an underlying medical condition), but it is often missed because current diagnostic tests are not accurate enough. This research aims to solve that problem by using advanced laboratory technology to create more reliable diagnostic thresholds, helping doctors identify and treat this curable cause of high blood pressure earlier.
You likely qualify if…
You likely don't qualify if…
If you are a healthy volunteer, you will have blood tests to establish normal hormone levels after receiving a test medication. If you are a patient suspected of having primary aldosteronism, you will have blood tests done as part of a diagnostic protocol, then receive 4 weeks of treatment with spironolactone while researchers monitor your response and collect follow-up blood samples. All participants will need to attend clinic visits for blood draws and blood pressure checks.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
China